OS4 – The Essence of Perfection

Article

Become a witness when Oertli is launching their new anterior and vitreoretinal surgery platform and experience another international sensation made in Switzerland.

OS4 – The Essence of Perfection

When the best engineers and designers give their best, they are bound to develop the best machine. "We have redefined the concept of the operating platform for cataract, glaucoma and retina surgery. The OS4 includes everything we are good at: cutting-edge technology, perfect design, irresistible simplicity, the highest degree of safety and Swiss quality. In short: 100 percent Oertli®", states Thomas Bosshard, Head of Marketing & Sales.

From 12 to 16 September 2014, the OS4 will see its world premiere at the ESCRS in London. At the Oertli booth B09, you become a witness when the OS4 makes its way to the most advanced operation theaters in the world. You will have the pleasure of experience all the details of the brand new Swiss made device.

Contact details:


Fabienne Kast, Product Manager Anterior
fabienne.kast@oertli-instruments.comwww.oertli-os4.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.